Travere Therapeutics, Inc. (TVTX): EPS (Diluted)
-$0.29
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.29 | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$4.08 | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$1.50 | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$4.37 | n/m | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | -$3.01 | n/m | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | -$3.56 | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$3.46 | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$2.54 | n/m | 2019-02-26, From 2018-01-01 |
| 2017-12-31 | -$1.54 | n/m | 2019-02-26, From 2017-01-01 |
| 2016-12-31 | -$1.29 | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $3.17 | n/m | 2018-07-06, From 2015-01-01 |
| 2014-12-31 | -$4.43 | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$2.44 | n/a | 2016-02-26, From 2013-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$0.29 | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $1.06 | +165.0% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$3.78 | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | -$0.47 | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$0.16 | n/m |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $0.52 | n/m |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $0.15 | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $3.30 | +816.7% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$0.26 | n/m |
Compare TVTX, NATR, BBIO, MIRM side by side · Screen every company in Pharmaceutical Preparations ↗